Comment on: Cani et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance: Diabetes
By J. Amar, M. Iglesias, C. Knauf, F. Fava, C. Chabo, B. Cousin, G. Gibson, L. Casteilla, M. Alessi. 2007
659 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/a576984bebf52d4f8652c70ddf2ba045907026a9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Bjoern O. Schroeder
- Rosa Krajmalnik-Brown
- F. Bäckhed
- M. Schoeler
- Robert Caesar
- A. Chait
- Dae-Wook Kang
- Z. Ilhan
Citations in the corpus
- Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease (2020, background): “Such ectopic WAT areas are mostly located within the visceral cavity, and include intrahepatic (discussed in the section on Ectopic Abbreviations: ALT, Alanine transaminase; M2, Alternatively activated macrophages; AMPK, AMP-activated protein kinase; ARG1, arginase-1; AST, aspartate transaminase; β-”
- High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse (2010, background): “The induction of these proinflammatory biomarkers prior to the onset of significant weight gain (at 8 weeks) and measurable increases in adiposity (6 weeks), contrast with adipose inflammation, which typically occurs after onset of DIO.”
- Bifidobacteria or fiber protect against diet-induced microbiota-mediated colonic mucus deterioration (2017, background): “Moreover, metabolic disease can be initiated by microbial products, or potentially even intact bacteria, translocating from the intestine into the systemic circulation (Burcelin et al., 2013; Caesar et al., 2012; Cani et al., 2007; Everard et al., 2013; Teixeira et al., 2012).”
- The role of the gut microbiota in energy metabolism and metabolic disease. (2009, background): “The link between periodontal diseases and cardiovascular diseases is now well established [96-99].”
- Dietary lipids, gut microbiota and lipid metabolism (2019, background): “Mouse studies have shown that hepatic steatosis is induced by a high-fat diet and associated with dysbiosis and increased intestinal permeability [91].”
- Understanding the Holobiont: How microbial metabolites affect human health and shape the immune system (2017, background): “Well over a century ago, studies demonstrated that dietary changes can alter the type of metabolites produced by bacteria living in the healthy intestine (Hirschler, 1886), and that the composition of the intestinal microbiome itself depends on the composition of the consumed diet (Cannon, 1921; Her”
- Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development (2020, background): “Consistently, a continuous infusion of low-dose LPS to mimic metabolic endotoxemia leads to the development of Type 2 Diabetes Mellitus (T2DM) and atherosclerosis, emphasizing the causal relationship between intestinal barrier dysfunction and the development of metabolic diseases [54].”
- Effects of Gut Microbes on Nutrient Absorption and Energy Regulation (2012, background): “The presence of genetic and diet-induced obesity and other metabolic disorders has been associated with a substantial increase in LPS concentrations in the blood, a condition termed metabolic endotoxemia.(102,103) Obesity and a number of other metabolic disorders are characterized by chronic, system”